Intrafamily heterooligomerization as an emerging mechanism of methyltransferase regulation

Haley V. Hobble,Christine E. Schaner Tooley
DOI: https://doi.org/10.1186/s13072-024-00530-0
2024-03-04
Epigenetics & Chromatin
Abstract:Protein and nucleic acid methylation are important biochemical modifications. In addition to their well-established roles in gene regulation, they also regulate cell signaling, metabolism, and translation. Despite this high biological relevance, little is known about the general regulation of methyltransferase function. Methyltransferases are divided into superfamilies based on structural similarities and further classified into smaller families based on sequence/domain/target similarity. While members within superfamilies differ in substrate specificity, their structurally similar active sites indicate a potential for shared modes of regulation. Growing evidence from one superfamily suggests a common regulatory mode may be through heterooligomerization with other family members. Here, we describe examples of methyltransferase regulation through intrafamily heterooligomerization and discuss how this can be exploited for therapeutic use.
genetics & heredity
What problem does this paper attempt to address?
This paper attempts to explore new mechanisms by which methyltransferases are regulated through intrafamily heterooligomerization. Specifically, the authors describe examples of methyltransferases from three families (DNMT, PRMT, and METTL) in the 7βS superfamily being regulated through intrafamily heterooligomerization and discuss how these interactions can be used for therapeutic purposes. ### Main issues - **Function and regulation of methyltransferases**: Although methyltransferases play important roles in gene regulation, cell signaling, metabolism, and translation, little is known about the general regulatory mechanisms of their functions. This paper focuses on a new regulatory method - regulating the functions of methyltransferases by forming heterooligomers with other family members. - **Examples of heterooligomerization**: - **DNA methyltransferases (DNMT3A/DNMT3B/DNMT3L)**: DNMT3A and DNMT3B can form homodimers or tetramers, and can also form heterodimers or tetramers with DNMT3L. Although DNMT3L has no catalytic activity, it enhances the methylation activity of DNMT3A or DNMT3B by stabilizing their DNA - binding conformations. - **Protein arginine methyltransferases (PRMTs)**: PRMT1 can form heterodimers with PRMT6, PRMT2, and PRMT8. These interactions can change the substrate specificity and/or localization pattern of PRMT1, thereby enhancing its functional diversity. - **RNA methyltransferases (METTL3/METTL14)**: METTL3 and METTL14 form a heterodimer. Although METTL14 has no catalytic activity by itself, it activates the catalytic activity of METTL3 by providing structural support and assisting in RNA substrate binding. - **N - terminal methyltransferases (METTL11A/METTL11B/METTL13)**: METTL11A and METTL11B form a heterotrimer. METTL11B stabilizes and activates METTL11A by promoting the binding of non - classical substrates. In addition, METTL11A can also form a complex with METTL13, and they regulate each other's methylation activities. ### Main contributions of the paper - **Revealing new mechanisms**: This paper systematically describes for the first time multiple mechanisms by which methyltransferases are regulated through intrafamily heterooligomerization. - **Therapeutic potential**: It discusses how these interactions can be used to develop new treatment methods, especially for drug design in cancer and other diseases. - **Disease - related mutations**: It lists some methyltransferase mutations related to human diseases. These mutations affect the protein - protein interaction interfaces, further emphasizing the importance of understanding these interactions. In conclusion, this paper aims to provide a new perspective for understanding the regulatory mechanisms of methyltransferases and their potential applications in diseases through a detailed analysis of the heterooligomerization mechanisms of different methyltransferase families.